RESEDA, CA - January 07, 2026 - PRESSADVANTAGE - Moment of Clarity has published a new educational resource focused on ...
A new clinical practice update outlines a stepwise approach to diagnosing and managing refractory constipation before ...
“By focusing on rehabilitated individuals in this under-studied region, the research provides insights into the outcomes of ...
Understand which barriers to cancer trial participation remain most difficult to overcome, including geography and trial ...
A new partnership to promote Swedish clinical trials has been launched, but concerns remain about a lack of patient voices ...
The Print on MSN
India’s first dengue vaccine has been in the making for 17 yrs. DengiAll has the world excited
At the Panacea Biotec office, conversations around DengiAll are cloaked with an air of eagerness. With the human trials ...
As 2026 begins, a slate of high-stakes clinical readouts—from a pivotal study of Novartis’ cardiovascular candidate ...
When you were younger, you might have thought older adults went to bed early simply because they loved quiet mornings and a ...
The National Medical Commission withdrew approval for the MBBS course at Shri Mata Vaishno Devi Institute of Medical ...
Inside a single-story brick building in Sorrento Mesa is a small lab sprinkled with beakers, test tubes and incubators that ...
MedPage Today on MSN
Real-World Data Show Gout Treatment Disparities
In a 10-year propensity-matched cohort study, Irene Tan, MD, of the Einstein Healthcare Network and Jefferson Health in ...
Seborrheic dermatitis is positively associated with a range of epithelial barrier diseases, including dermatologic, respiratory, gastrointestinal, and ocular diseases.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results